[rev_slider alias=”new-activities” /]
Consorzio per Valutazioni Biologiche e Farmacologiche (CVBF) is a non-profit scientific organisation, founded in 2000 with the mission to perform research and education in the life sciences, biotechnologies, and pharmaceutical fields. Its main focus is drug development for small populations (paediatric and rare diseases).
Consorzio per Valutazioni Biologiche e Farmacologiche (CVBF) mission is to enhance technology-driven paediatric research in drug discovery and early development phases to be translated into clinical research. CVBF promotes networking within the scientific community and collaboration between stakeholders to harness efficiency of the European research infrastructures and delivery of research services. CVBF
supports adequate policies pushing towards higher scientific, ethical and societal standards for a better implementation of health systems and allocation of resources. CVBF activities are organised within two operational areas Development&Networking and Clinical Research.
Latest News
SAVE THE DATE: “Pharmacovigilance: common assessment tools and Promoter responsibility – 25 June 2019, Rome
On 25 June 2019, a workshop entitled “ Pharmacovigilance: common assessment tools and Promoter responsibility” will be held at University Polyclinic “Agostino Gemelli” in Rome. Dr. Mariagrazia Felisi, Clinical Research Director at Consorzio per Valutazioni [...]
Newsletter, November 2024
Newsletter, November 2024 Since its inception, CVBF has been more than just a research organization - it's a mission-driven community dedicated to transforming the landscape of paediatric and rare disease research. We dedicate a special focus [...]
EU Health Summit 2025: Reshaping Health for a Stronger Europe
The EU Health Coalition, with CVBF as a proud member, invites you to the EU Health Summit on 28 January 2025, in Brussels. This event will tackle pressing challenges in European healthcare and outline strategic [...]
